Covered recipient · General Payments record
LAURA SKUFCA
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health
General Payments · PY2021–2023
$1,716.56
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $749.95 | 17 |
| Education | $2.93 | 1 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Alkermes, Inc. | $208.81 | 9 |
| ABBVIE INC. | $177.68 | 5 |
| Neurocrine BioSciences, Inc. | $124.99 | 1 |
| Teva Pharmaceuticals USA, Inc. | $121.19 | 2 |
| Axsome Therapeutics, Inc. | $120.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.17 | 01/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009835737 | CMS |
| ABBVIE INC. | $20.00 | 02/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009835741 | CMS |
| ABBVIE INC. | $117.21 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009835745 | CMS |
| ABBVIE INC. | $14.59 | 03/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009835749 | CMS |
| ABBVIE INC. | $5.71 | 03/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1009835753 | CMS |
| Alkermes, Inc. | $119.97 | 01/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022918709 | CMS |
| Alkermes, Inc. | $10.68 | 02/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022918711 | CMS |
| Alkermes, Inc. | $6.38 | 05/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022918713 | CMS |
| Alkermes, Inc. | $12.79 | 05/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022918715 | CMS |
| Alkermes, Inc. | $15.83 | 06/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022918717 | CMS |
| Alkermes, Inc. | $19.44 | 07/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022918719 | CMS |
| Alkermes, Inc. | $9.11 | 10/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022918721 | CMS |
| Alkermes, Inc. | $11.68 | 10/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1022918723 | CMS |
| Alkermes, Inc. | $2.93 | 12/05/2023 | Education | Undisputed | 01/23/2026 | 1022918725 | CMS |
| Axsome Therapeutics, Inc. | $120.21 | 06/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056332255 | CMS |
| Neurocrine Biosciences, Inc. | $124.99 | 06/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1052199961 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.78 | 05/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056945775 | CMS |
| Teva Pharmaceuticals USA, Inc. | $107.41 | 06/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1056945847 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.